Dr. William "Bill" Larkins
Executive Vice President and Chief Scientific Officer and President, Sterile Injectables
Dr. William “Bill” Larkins serves as Executive Vice President and Chief Scientific Officer and President, Sterile Injectables of Par Health, leading the company’s R&D function and sterile injectables segment.
Dr. Larkins brings more than 30 years of experience in sterile injectables and most recently served as President, Global Injectables at Hikma Pharmaceuticals from September 2023 through the end of 2025, where he drove strong revenue growth in all regions and launched hundreds of new products. In that role, he also oversaw R&D and Regulatory Affairs for the Global Injectables Unit, leading innovation, pipeline and product approvals.
Dr. Larkins joined Hikma in 2022 as Senior Vice President of R&D for Injectables following its acquisition of Custopharm, Inc., where he served as Chief Executive Officer for eight years. Throughout his distinguished career, Dr. Larkins has held senior leadership roles at leading pharmaceutical companies, including Bedford Laboratories, Amylin Pharmaceuticals, Sandoz, ESI Lederle/Baxter and Barr Laboratories.
Dr. Larkins earned a Ph.D. in Analytical Chemistry from The Ohio State University and holds a B.S. in Chemistry from Purdue University.